Strategic Capital Advisers Inc. Buys New Shares in UnitedHealth Group Inc (NYSE:UNH)

Strategic Capital Advisers Inc. bought a new stake in UnitedHealth Group Inc (NYSE:UNH) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 2,000 shares of the healthcare conglomerate’s stock, valued at approximately $488,000.

A number of other institutional investors also recently added to or reduced their stakes in the stock. FMR LLC grew its holdings in UnitedHealth Group by 1.9% in the fourth quarter. FMR LLC now owns 64,480,003 shares of the healthcare conglomerate’s stock valued at $16,063,258,000 after purchasing an additional 1,232,189 shares during the period. Geode Capital Management LLC grew its holdings in UnitedHealth Group by 9.1% in the fourth quarter. Geode Capital Management LLC now owns 11,593,401 shares of the healthcare conglomerate’s stock valued at $2,882,988,000 after purchasing an additional 965,763 shares during the period. Norges Bank purchased a new stake in UnitedHealth Group in the fourth quarter valued at approximately $2,343,175,000. American Century Companies Inc. grew its holdings in UnitedHealth Group by 12.8% in the fourth quarter. American Century Companies Inc. now owns 5,678,706 shares of the healthcare conglomerate’s stock valued at $1,414,679,000 after purchasing an additional 644,872 shares during the period. Finally, Legal & General Group Plc grew its holdings in UnitedHealth Group by 9.0% in the fourth quarter. Legal & General Group Plc now owns 4,747,709 shares of the healthcare conglomerate’s stock valued at $1,182,721,000 after purchasing an additional 391,437 shares during the period. Hedge funds and other institutional investors own 85.87% of the company’s stock.

In other news, Director William C. Ballard, Jr. sold 12,000 shares of the business’s stock in a transaction on Tuesday, July 23rd. The shares were sold at an average price of $255.31, for a total transaction of $3,063,720.00. Following the transaction, the director now directly owns 61,309 shares of the company’s stock, valued at $15,652,800.79. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Richard T. Burke sold 10,000 shares of the business’s stock in a transaction on Tuesday, June 11th. The stock was sold at an average price of $248.00, for a total transaction of $2,480,000.00. Following the transaction, the director now directly owns 187,663 shares in the company, valued at $46,540,424. The disclosure for this sale can be found here. Over the last three months, insiders have sold 32,000 shares of company stock worth $7,963,620. Corporate insiders own 0.87% of the company’s stock.

Shares of NYSE UNH traded up $1.01 during trading on Friday, reaching $248.63. 2,322,195 shares of the stock were exchanged, compared to its average volume of 3,650,393. The business’s 50-day moving average price is $251.66. UnitedHealth Group Inc has a twelve month low of $208.07 and a twelve month high of $287.94. The company has a quick ratio of 0.73, a current ratio of 0.67 and a debt-to-equity ratio of 0.62. The company has a market cap of $234.66 billion, a P/E ratio of 19.30, a price-to-earnings-growth ratio of 1.32 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 EPS for the quarter, topping analysts’ consensus estimates of $3.46 by $0.14. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. The business had revenue of $60.60 billion for the quarter, compared to analysts’ expectations of $60.59 billion. During the same period in the previous year, the company posted $3.14 earnings per share. The business’s revenue for the quarter was up 8.0% compared to the same quarter last year. Equities analysts anticipate that UnitedHealth Group Inc will post 14.82 earnings per share for the current year.

UNH has been the subject of several research reports. Bank of America reiterated a “buy” rating and set a $290.00 price objective (down from $320.00) on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Zacks Investment Research upgraded shares of UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 price objective for the company in a research note on Monday, July 22nd. Cantor Fitzgerald set a $310.00 price objective on shares of UnitedHealth Group and gave the stock a “buy” rating in a research note on Friday, July 19th. SunTrust Banks decreased their price objective on shares of UnitedHealth Group to $300.00 and set a “buy” rating for the company in a research note on Wednesday, April 17th. They noted that the move was a valuation call. Finally, Royal Bank of Canada set a $311.00 price objective on shares of UnitedHealth Group and gave the stock a “buy” rating in a research note on Friday, July 19th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and eighteen have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $295.06.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Article: Price-Sales Ratio

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.